TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Swedish Biomedical Consulting AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
32
|
245
|
156 |
Financial expenses |
0
|
46
|
0 |
Earnings before taxes |
305
|
102
|
74 |
EBITDA |
-50
|
148
|
74 |
Total assets |
725
|
412
|
332 |
Current assets |
725
|
412
|
332 |
Current liabilities |
332
|
220
|
233 |
Equity capital |
393
|
192
|
98 |
- share capital |
51
|
47
|
49 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
54.2%
|
46.6%
|
29.5% |
Turnover per employee |
32
|
245
|
156 |
Profit as a percentage of turnover |
953.1%
|
41.6%
|
47.4% |
Return on assets (ROA) |
42.1%
|
35.9%
|
22.3% |
Current ratio |
218.4%
|
187.3%
|
142.5% |
Return on equity (ROE) |
77.6%
|
53.1%
|
75.5% |
Change turnover |
-230
|
94
|
156 |
Change turnover % |
-88%
|
62% | |
Chg. No. of employees |
0
![]() |
0
|
1 |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.